2015 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.




Preclinical Study Evaluates Primary Lesion Treatment With CSI’s Orbital Atherectomy System Before Drug Delivery in Calcified PAD

May 20, 2015 -- CBSET, a preclinical biomedical research institute, announced findings from a cadaver study suggesting that modification of atherosclerotic plaque with th…

Studies Evaluate Medtronic’s In.Pact Admiral DCB in Long Lesions

May 20, 2015 -- Medtronic plc announced the presentation of new clinical data from two different studies, the IN.PACT Global Study's long lesion imaging cohort a…

EuroPCR Lecture Encourages Adoption of New Generation of Mechanical Thrombectomy Devices for Stroke Treatment

May 20, 2015 -- Experts speaking at the EuroPCR 2015 conference stated that the numerous positive results for stent retrievers, the new-generation endovascular devices for the…

GE Healthcare’s Visipaque Use During Angioplasty Shown to Reduce Risk of Adverse Events

May 19, 2015 -- GE Healthcare announced that data from abstracts presented at EuroPCR show that significantly fewer renal and cardiac events are associated with angioplasty pr…

Shockwave Medical Gains $40 Million in Funding for Lithoplasty System

May 19, 2015 -- Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock, with the participation of RA Capi…

FDA Approves Silk Road Medical’s Enroute Transcarotid Stent System

May 19, 2015 -- Silk Road Medical, Inc. announced the company has received premarket approval (PMA) from the US Food and Drug Administration (FDA) for the Enroute transcarotid…

Nitiloop’s NovaCross Microcatheter Cleared by FDA

May 18, 2015 -- Nitiloop announced that it has received US Food and Drug Administration 510(k) clearance for its NovaCross device, which is intended to be used with …

Click here for more News coverage

Current Supplement


Control the Flow

Overcoming Global Procedural Challenges: Liver Cancer, Gastric Varices, and Enlarged Prostate

physician counsel

Open Payments Update: Will More Data + More Errors = More Physician Peril?

An early look at samples from the full 2014 Open Payments records suggests that physicians must be ready to review and dispute their records before they go public.

Open Payments Errors Could Put Physicians in a Bad Light

As the Open Payments website becomes more user-friendly, physicians must ensure their disclosures are accurate, or risk misinterpretation.

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center




Vascular Market Price  Change
Abbott Laboratories $49.03  0.00%
AstraZeneca PLC $69.45  0.00%
Boston Scientific Corporation $17.83  0.00%
BTG plc $726.50  0.00%
Cardiovascular Systems Inc. $27.93  0.00%
CR Bard Inc. $171.95  0.00%
Edwards Lifesciences Corp. $130.88  0.00%
Endologix Inc. $16.45  0.00%
Hansen Medical, Inc. $1.00  0.00%
Vascular Market Price  Change
Johnson and Johnson $101.35  0.00%
Lombard Medical, Inc. $5.47  0.00%
Medtronic, Inc. $77.82  0.00%
Merit Medical Systems, Inc. $20.27  0.00%
St. Jude Medical Inc. $74.27  0.00%
The Medicines Company $27.09  0.00%
The Spectranetics Corporation $24.27  0.00%
TriVascular Technologies, Inc. $5.85  0.00%
Vascular Solutions Inc. $33.09  0.00%


Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.

Website Design by Sides Media